JENNIFER L FLORES

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAN ANTONIO, TX NPI 1508405085

General Payments — all program years on this page

$846.68

  • Category: General Payments
  • Program years: PY2024
  • Record count: 21
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $846.68 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $846.6821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2024 $846.6821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086315123 Bayer Healthcare Pharmaceuticals Inc. $16.82 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089369290 Sandoz Inc. $33.54 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100362439 Novo Nordisk Inc $20.78 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100375927 Novo Nordisk Inc $26.11 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100457198 Novo Nordisk Inc $21.25 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100515953 Novo Nordisk Inc $20.43 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100618720 Novo Nordisk Inc $25.46 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107113207 ABBVIE INC. $16.00 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117554449 Amgen Inc. $14.76 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119071680 Otsuka America Pharmaceutical, Inc. $19.67 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131512679 PFIZER INC. $23.80 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135644168 Lilly USA, LLC $117.43 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135682561 Lilly USA, LLC $16.71 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135702391 Lilly USA, LLC $10.33 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568037 Teva Pharmaceuticals USA, Inc. $16.45 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568063 Teva Pharmaceuticals USA, Inc. $124.99 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568067 Teva Pharmaceuticals USA, Inc. $14.05 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568093 Teva Pharmaceuticals USA, Inc. $124.99 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568107 Teva Pharmaceuticals USA, Inc. $30.84 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568121 Teva Pharmaceuticals USA, Inc. $27.28 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151568135 Teva Pharmaceuticals USA, Inc. $124.99 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.